![Michael Perry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Perry
Direktor/Vorstandsmitglied bei
ARROWHEAD PHARMACEUTICALS, INC.
Vermögen: 10 Mio $ am 31.05.2026
Profil
Michael S.
Perry currently works at 7 Hills Pharma LLC, as Chairman from 2022, Arrowhead Pharmaceuticals, Inc., as Lead Independent Director from 2011, Rosetta Capital Ltd., as Director from 2017, and various other companies.
Dr. Perry also formerly worked at Systemix, Inc., as President & Chief Executive Officer from 1997 to 2000, Pharsight Corp., as President & Chief Executive Officer from 2002 to 2003, Extropy Pharmaceuticals, Inc., as Chairman & Chief Executive Officer from 2003 to 2005, and various other companies.
Dr. Perry received his undergraduate degree and doctorate degree from the University of Guelph, graduate degree from Harvard Business School, and doctorate degree from Ontario Veterinary College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.01.2026 | 123.059 ( 0,09 % ) | 10 Mio $ | 31.05.2026 |
Aktive Positionen von Michael Perry
| Unternehmen | Position | Beginn |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 19.12.2011 |
7 Hills Pharma LLC
 7 Hills Pharma LLC Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer treatment | Vorsitzender | 01.01.2022 |
Gamida Cell, Inc.
 Gamida Cell, Inc. BiotechnologyHealth Technology Develops cellular and immune therapeutics | Direktor/Vorstandsmitglied | - |
Bioscience Managers Pty Ltd.
 Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Private Equity Investor | 01.10.2020 |
Rosetta Capital Ltd.
 Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital invests in early and mid-stage growth companies in biotechnology-related sectors. The firm invest in acquisition financing and spin-off transactions. | Private Equity Investor | 30.10.2017 |
Ehemalige bekannte Positionen von Michael Perry
| Unternehmen | Position | Ende |
|---|---|---|
| AROVELLA THERAPEUTICS LIMITED | Direktor/Vorstandsmitglied | 04.05.2026 |
| AVITA MEDICAL, INC. | Vorstandsvorsitzender | 29.09.2022 |
AVITA Medical Pty Ltd.
 AVITA Medical Pty Ltd. BiotechnologyHealth Technology Develops and distributes products in regenerative and respiratory medicine | Vorstandsvorsitzender | 29.09.2022 |
| GAMIDA CELL LTD. | Direktor/Vorstandsmitglied | 01.05.2021 |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Michael Perry
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
61
Beziehungen ersten Grades
29
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 29 |
|---|---|
Poniard Pharmaceuticals, Inc.
 Poniard Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic biopharmaceuticals, primarily for the treatment of cancer, cardiovascular and inflammatory diseases | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Syntex Corp.
 Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Health Technology |
BioTransplant, Inc.
 BioTransplant, Inc. Pharmaceuticals: MajorHealth Technology Discover, develop and commercialize therapeutics, therapeutic devices & therapeutic regimens | Health Technology |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Develops cell-based gene therapies for diseases | Health Services |
Arrowhead Pharmaceuticals, Inc.
 Arrowhead Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drugs to treat intractable diseases | Health Technology |
Pharsight Corp.
 Pharsight Corp. Packaged SoftwareTechnology Services Develops computer-assisted trial design software | Technology Services |
Extropy Pharmaceuticals, Inc. | |
VIA Pharmaceuticals, Inc. /Old/
 VIA Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Genetic Therapy, Inc.
 Genetic Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Develops human gene therapy delivery products | Commercial Services |
Arovella Therapeutics Ltd.
 Arovella Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and distributes medical devices and consumables | Health Technology |
University of Guelph
 University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital invests in public and private companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital transactions. The firm makes co-investments. It acts as a lead investor and takes a seat on the board of directors. | Finance |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Rosetta Capital Ltd.
Rosetta Capital Ltd. Investment ManagersFinance Rosetta Capital invests in early and mid-stage growth companies in biotechnology-related sectors. The firm invest in acquisition financing and spin-off transactions. | Finance |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Health Technology |
Xeno Transplants Corp.
 Xeno Transplants Corp. BiotechnologyHealth Technology Develops therapeutic applications | Health Technology |
Gamida Cell Ltd.
 Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
Sandoz Pharmaceuticals Corp. | |
AVITA Medical Pty Ltd.
AVITA Medical Pty Ltd. BiotechnologyHealth Technology Develops and distributes products in regenerative and respiratory medicine | Health Technology |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Finance |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ontario Veterinary College
 Ontario Veterinary College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Armata Pharmaceuticals, Inc.
 Armata Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on the development and commercialization of novel targeted antimicrobials | Health Technology |
Gamida Cell, Inc.
Gamida Cell, Inc. BiotechnologyHealth Technology Develops cellular and immune therapeutics | Health Technology |
AVITA Medical, Inc.
 AVITA Medical, Inc. Medical SpecialtiesHealth Technology Develops and commercializes medical devices for regenerative medicine | Health Technology |
7 Hills Pharma LLC
7 Hills Pharma LLC Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer treatment | Health Technology |
